Global Aesthetic Medicine

Aesthetic Medicine Comprehensive Study by Type (Injectable Fillers, Cream, Ointment, Capsules, Others), Application (Instant Rejuvenation, Wrinkle Prevention, Weight Loss, Skin Tightening, Others), End Use (Hospitals, Ambulatory Surgical Clinics, Dermatology Clinics, Others), Sales Channel (Direct Sale, Indirect Sales {Pharmacies, E-commerce, and Others}), Procedure (Surgical {Liposuction, Breast augmentation, Eyelid Surgery, Nose reshaping, and Others}, Non-Surgical {Chemical Peel, Botox injections, Soft Tissue Fillers, Laser Hair Removal, Microdermabrasion, and Others}) Players and Region - Global Market Outlook to 2030

Aesthetic Medicine Market by XX Submarkets | Forecast Years 2024-2030  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Aesthetic Medicine
Aesthetic Medicine comprises all medical procedures that are intended at enhancing the physical appearance of the user with non-invasive or minimally invasive cosmetic measures. Aesthetic Medicine is not only limited to dermatologists and plastic surgeons as physicians of all specialties offer services to address the patient's aesthetic requirements and needs. Some Aesthetic Medicine procedures are performed under local anesthesia while some procedures don't require anesthesia at all

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)


The market for Aesthetic Medicines is fragmented with the presence of international as well as local players. The companies may be involved in implementing strategies like mergers, acquisitions, collaborations, and new improved product launches to increase their market share. An increase in the market of Aesthetic Medicines can be predicted due to the increasing awareness about aesthetics Analyst at AMA Research estimates that United States and European Players will contribute the maximum growth to Global Aesthetic Medicine market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Allergan (Ireland), Alma Laser (United States), Cynosure (United States), Galderma (Switzerland), Johnson and Johnson (United States), Solta Medical International Inc. (United States), Syneron Medical (United States), Skin Tech Pharma Group (Spain), Sinclair Pharm (United Kingdom), Candela Medical (United States) and Lumenis (Israel) are some of the key players that are part of study coverage.

Segmentation Overview
AMA Research has segmented the market of Global Aesthetic Medicine market by Type (Injectable Fillers, Cream, Ointment, Capsules and Others), Application (Instant Rejuvenation, Wrinkle Prevention, Weight Loss, Skin Tightening and Others) and Region.



On the basis of geography, the market of Aesthetic Medicine has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by End Use, the sub-segment i.e. Hospitals will boost the Aesthetic Medicine market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Sales Channel, the sub-segment i.e. Direct Sale will boost the Aesthetic Medicine market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Procedure, the sub-segment i.e. Surgical {Liposuction, Breast augmentation, Eyelid Surgery, Nose reshaping, and Others} will boost the Aesthetic Medicine market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
The rising popularity of non-invasive aesthetic medicines

Market Growth Drivers:
Increased aesthetics consciousness in people with signs of aging, wrinkles, loose facial skin and dark spots looking surgical or non-surgical corrective measures to enhance their appearance and Presence of large geriatric population and adults prone to dermatological problems owing to unhealthy and hectic lifestyle

Challenges:
Side effects associated with the usage of aesthetic medicines and High Cost linked with the applications of aesthetic medicines

Restraints:
Stringent regulatory measures concerning the safety and efficiency of aesthetic medicines

Opportunities:
There is an increased opportunity for pharmaceuticals companies for meeting the expanding demands for people looking for enhancing their appearance and Over the counter availability of the aesthetic medicines can boost the market share for pharmacies and specialty stores

Market Leaders and their expansionary development strategies
In January 2020, Allergan announced the launch of the SkinMedica® Instant Bright Eye Cream for enhancing the skin around eyes and In July 2019, Cynosure division announced the launch of two new aesthetic treatments products-the TempSure® Firm handpiece and a petite mask for SculpSure® submental treatments



Key Target Audience
Pharmaceutical Companies, Healthcare Companies, Investors, Distributors/Traders, Importers/Exporters, Regulatory and Government Bodies, Downstream Vendors, Up-Stream Vendors, End Users and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Injectable Fillers
  • Cream
  • Ointment
  • Capsules
  • Others
By Application
  • Instant Rejuvenation
  • Wrinkle Prevention
  • Weight Loss
  • Skin Tightening
  • Others
By End Use
  • Hospitals
  • Ambulatory Surgical Clinics
  • Dermatology Clinics
  • Others

By Sales Channel
  • Direct Sale
  • Indirect Sales {Pharmacies, E-commerce, and Others}

By Procedure
  • Surgical {Liposuction, Breast augmentation, Eyelid Surgery, Nose reshaping, and Others}
  • Non-Surgical {Chemical Peel, Botox injections, Soft Tissue Fillers, Laser Hair Removal, Microdermabrasion, and Others}

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increased aesthetics consciousness in people with signs of aging, wrinkles, loose facial skin and dark spots looking surgical or non-surgical corrective measures to enhance their appearance
      • 3.2.2. Presence of large geriatric population and adults prone to dermatological problems owing to unhealthy and hectic lifestyle
    • 3.3. Market Challenges
      • 3.3.1. Side effects associated with the usage of aesthetic medicines
      • 3.3.2. High Cost linked with the applications of aesthetic medicines
    • 3.4. Market Trends
      • 3.4.1. The rising popularity of non-invasive aesthetic medicines
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Aesthetic Medicine, by Type, Application, End Use, Sales Channel, Procedure and Region (value, volume and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Aesthetic Medicine (Value)
      • 5.2.1. Global Aesthetic Medicine by: Type (Value)
        • 5.2.1.1. Injectable Fillers
        • 5.2.1.2. Cream
        • 5.2.1.3. Ointment
        • 5.2.1.4. Capsules
        • 5.2.1.5. Others
      • 5.2.2. Global Aesthetic Medicine by: Application (Value)
        • 5.2.2.1. Instant Rejuvenation
        • 5.2.2.2. Wrinkle Prevention
        • 5.2.2.3. Weight Loss
        • 5.2.2.4. Skin Tightening
        • 5.2.2.5. Others
      • 5.2.3. Global Aesthetic Medicine by: End Use (Value)
        • 5.2.3.1. Hospitals
        • 5.2.3.2. Ambulatory Surgical Clinics
        • 5.2.3.3. Dermatology Clinics
        • 5.2.3.4. Others
      • 5.2.4. Global Aesthetic Medicine by: Sales Channel (Value)
        • 5.2.4.1. Direct Sale
        • 5.2.4.2. Indirect Sales {Pharmacies, E-commerce, and Others}
      • 5.2.5. Global Aesthetic Medicine by: Procedure (Value)
        • 5.2.5.1. Surgical {Liposuction, Breast augmentation, Eyelid Surgery, Nose reshaping, and Others}
        • 5.2.5.2. Non-Surgical {Chemical Peel, Botox injections, Soft Tissue Fillers, Laser Hair Removal, Microdermabrasion, and Others}
      • 5.2.6. Global Aesthetic Medicine Region
        • 5.2.6.1. South America
          • 5.2.6.1.1. Brazil
          • 5.2.6.1.2. Argentina
          • 5.2.6.1.3. Rest of South America
        • 5.2.6.2. Asia Pacific
          • 5.2.6.2.1. China
          • 5.2.6.2.2. Japan
          • 5.2.6.2.3. India
          • 5.2.6.2.4. South Korea
          • 5.2.6.2.5. Taiwan
          • 5.2.6.2.6. Australia
          • 5.2.6.2.7. Rest of Asia-Pacific
        • 5.2.6.3. Europe
          • 5.2.6.3.1. Germany
          • 5.2.6.3.2. France
          • 5.2.6.3.3. Italy
          • 5.2.6.3.4. United Kingdom
          • 5.2.6.3.5. Netherlands
          • 5.2.6.3.6. Rest of Europe
        • 5.2.6.4. MEA
          • 5.2.6.4.1. Middle East
          • 5.2.6.4.2. Africa
        • 5.2.6.5. North America
          • 5.2.6.5.1. United States
          • 5.2.6.5.2. Canada
          • 5.2.6.5.3. Mexico
    • 5.3. Global Aesthetic Medicine (Volume)
      • 5.3.1. Global Aesthetic Medicine by: Type (Volume)
        • 5.3.1.1. Injectable Fillers
        • 5.3.1.2. Cream
        • 5.3.1.3. Ointment
        • 5.3.1.4. Capsules
        • 5.3.1.5. Others
      • 5.3.2. Global Aesthetic Medicine by: Application (Volume)
        • 5.3.2.1. Instant Rejuvenation
        • 5.3.2.2. Wrinkle Prevention
        • 5.3.2.3. Weight Loss
        • 5.3.2.4. Skin Tightening
        • 5.3.2.5. Others
      • 5.3.3. Global Aesthetic Medicine by: End Use (Volume)
        • 5.3.3.1. Hospitals
        • 5.3.3.2. Ambulatory Surgical Clinics
        • 5.3.3.3. Dermatology Clinics
        • 5.3.3.4. Others
      • 5.3.4. Global Aesthetic Medicine by: Sales Channel (Volume)
        • 5.3.4.1. Direct Sale
        • 5.3.4.2. Indirect Sales {Pharmacies, E-commerce, and Others}
      • 5.3.5. Global Aesthetic Medicine by: Procedure (Volume)
        • 5.3.5.1. Surgical {Liposuction, Breast augmentation, Eyelid Surgery, Nose reshaping, and Others}
        • 5.3.5.2. Non-Surgical {Chemical Peel, Botox injections, Soft Tissue Fillers, Laser Hair Removal, Microdermabrasion, and Others}
      • 5.3.6. Global Aesthetic Medicine Region
        • 5.3.6.1. South America
          • 5.3.6.1.1. Brazil
          • 5.3.6.1.2. Argentina
          • 5.3.6.1.3. Rest of South America
        • 5.3.6.2. Asia Pacific
          • 5.3.6.2.1. China
          • 5.3.6.2.2. Japan
          • 5.3.6.2.3. India
          • 5.3.6.2.4. South Korea
          • 5.3.6.2.5. Taiwan
          • 5.3.6.2.6. Australia
          • 5.3.6.2.7. Rest of Asia-Pacific
        • 5.3.6.3. Europe
          • 5.3.6.3.1. Germany
          • 5.3.6.3.2. France
          • 5.3.6.3.3. Italy
          • 5.3.6.3.4. United Kingdom
          • 5.3.6.3.5. Netherlands
          • 5.3.6.3.6. Rest of Europe
        • 5.3.6.4. MEA
          • 5.3.6.4.1. Middle East
          • 5.3.6.4.2. Africa
        • 5.3.6.5. North America
          • 5.3.6.5.1. United States
          • 5.3.6.5.2. Canada
          • 5.3.6.5.3. Mexico
    • 5.4. Global Aesthetic Medicine (Price)
      • 5.4.1. Global Aesthetic Medicine by: Type (Price)
  • 6. Aesthetic Medicine: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Allergan (Ireland)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Alma Laser (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Cynosure (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Galderma (Switzerland)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Johnson and Johnson (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Solta Medical International Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Syneron Medical (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Skin Tech Pharma Group (Spain)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Sinclair Pharm (United Kingdom)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Candela Medical (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Lumenis (Israel)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
  • 7. Global Aesthetic Medicine Sale, by Type, Application, End Use, Sales Channel, Procedure and Region (value, volume and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Aesthetic Medicine (Value)
      • 7.2.1. Global Aesthetic Medicine by: Type (Value)
        • 7.2.1.1. Injectable Fillers
        • 7.2.1.2. Cream
        • 7.2.1.3. Ointment
        • 7.2.1.4. Capsules
        • 7.2.1.5. Others
      • 7.2.2. Global Aesthetic Medicine by: Application (Value)
        • 7.2.2.1. Instant Rejuvenation
        • 7.2.2.2. Wrinkle Prevention
        • 7.2.2.3. Weight Loss
        • 7.2.2.4. Skin Tightening
        • 7.2.2.5. Others
      • 7.2.3. Global Aesthetic Medicine by: End Use (Value)
        • 7.2.3.1. Hospitals
        • 7.2.3.2. Ambulatory Surgical Clinics
        • 7.2.3.3. Dermatology Clinics
        • 7.2.3.4. Others
      • 7.2.4. Global Aesthetic Medicine by: Sales Channel (Value)
        • 7.2.4.1. Direct Sale
        • 7.2.4.2. Indirect Sales {Pharmacies, E-commerce, and Others}
      • 7.2.5. Global Aesthetic Medicine by: Procedure (Value)
        • 7.2.5.1. Surgical {Liposuction, Breast augmentation, Eyelid Surgery, Nose reshaping, and Others}
        • 7.2.5.2. Non-Surgical {Chemical Peel, Botox injections, Soft Tissue Fillers, Laser Hair Removal, Microdermabrasion, and Others}
      • 7.2.6. Global Aesthetic Medicine Region
        • 7.2.6.1. South America
          • 7.2.6.1.1. Brazil
          • 7.2.6.1.2. Argentina
          • 7.2.6.1.3. Rest of South America
        • 7.2.6.2. Asia Pacific
          • 7.2.6.2.1. China
          • 7.2.6.2.2. Japan
          • 7.2.6.2.3. India
          • 7.2.6.2.4. South Korea
          • 7.2.6.2.5. Taiwan
          • 7.2.6.2.6. Australia
          • 7.2.6.2.7. Rest of Asia-Pacific
        • 7.2.6.3. Europe
          • 7.2.6.3.1. Germany
          • 7.2.6.3.2. France
          • 7.2.6.3.3. Italy
          • 7.2.6.3.4. United Kingdom
          • 7.2.6.3.5. Netherlands
          • 7.2.6.3.6. Rest of Europe
        • 7.2.6.4. MEA
          • 7.2.6.4.1. Middle East
          • 7.2.6.4.2. Africa
        • 7.2.6.5. North America
          • 7.2.6.5.1. United States
          • 7.2.6.5.2. Canada
          • 7.2.6.5.3. Mexico
    • 7.3. Global Aesthetic Medicine (Volume)
      • 7.3.1. Global Aesthetic Medicine by: Type (Volume)
        • 7.3.1.1. Injectable Fillers
        • 7.3.1.2. Cream
        • 7.3.1.3. Ointment
        • 7.3.1.4. Capsules
        • 7.3.1.5. Others
      • 7.3.2. Global Aesthetic Medicine by: Application (Volume)
        • 7.3.2.1. Instant Rejuvenation
        • 7.3.2.2. Wrinkle Prevention
        • 7.3.2.3. Weight Loss
        • 7.3.2.4. Skin Tightening
        • 7.3.2.5. Others
      • 7.3.3. Global Aesthetic Medicine by: End Use (Volume)
        • 7.3.3.1. Hospitals
        • 7.3.3.2. Ambulatory Surgical Clinics
        • 7.3.3.3. Dermatology Clinics
        • 7.3.3.4. Others
      • 7.3.4. Global Aesthetic Medicine by: Sales Channel (Volume)
        • 7.3.4.1. Direct Sale
        • 7.3.4.2. Indirect Sales {Pharmacies, E-commerce, and Others}
      • 7.3.5. Global Aesthetic Medicine by: Procedure (Volume)
        • 7.3.5.1. Surgical {Liposuction, Breast augmentation, Eyelid Surgery, Nose reshaping, and Others}
        • 7.3.5.2. Non-Surgical {Chemical Peel, Botox injections, Soft Tissue Fillers, Laser Hair Removal, Microdermabrasion, and Others}
      • 7.3.6. Global Aesthetic Medicine Region
        • 7.3.6.1. South America
          • 7.3.6.1.1. Brazil
          • 7.3.6.1.2. Argentina
          • 7.3.6.1.3. Rest of South America
        • 7.3.6.2. Asia Pacific
          • 7.3.6.2.1. China
          • 7.3.6.2.2. Japan
          • 7.3.6.2.3. India
          • 7.3.6.2.4. South Korea
          • 7.3.6.2.5. Taiwan
          • 7.3.6.2.6. Australia
          • 7.3.6.2.7. Rest of Asia-Pacific
        • 7.3.6.3. Europe
          • 7.3.6.3.1. Germany
          • 7.3.6.3.2. France
          • 7.3.6.3.3. Italy
          • 7.3.6.3.4. United Kingdom
          • 7.3.6.3.5. Netherlands
          • 7.3.6.3.6. Rest of Europe
        • 7.3.6.4. MEA
          • 7.3.6.4.1. Middle East
          • 7.3.6.4.2. Africa
        • 7.3.6.5. North America
          • 7.3.6.5.1. United States
          • 7.3.6.5.2. Canada
          • 7.3.6.5.3. Mexico
    • 7.4. Global Aesthetic Medicine (Price)
      • 7.4.1. Global Aesthetic Medicine by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Aesthetic Medicine: by Type(USD Million)
  • Table 2. Aesthetic Medicine Injectable Fillers , by Region USD Million (2018-2023)
  • Table 3. Aesthetic Medicine Cream , by Region USD Million (2018-2023)
  • Table 4. Aesthetic Medicine Ointment , by Region USD Million (2018-2023)
  • Table 5. Aesthetic Medicine Capsules , by Region USD Million (2018-2023)
  • Table 6. Aesthetic Medicine Others , by Region USD Million (2018-2023)
  • Table 7. Aesthetic Medicine: by Application(USD Million)
  • Table 8. Aesthetic Medicine Instant Rejuvenation , by Region USD Million (2018-2023)
  • Table 9. Aesthetic Medicine Wrinkle Prevention , by Region USD Million (2018-2023)
  • Table 10. Aesthetic Medicine Weight Loss , by Region USD Million (2018-2023)
  • Table 11. Aesthetic Medicine Skin Tightening , by Region USD Million (2018-2023)
  • Table 12. Aesthetic Medicine Others , by Region USD Million (2018-2023)
  • Table 13. Aesthetic Medicine: by End Use(USD Million)
  • Table 14. Aesthetic Medicine Hospitals , by Region USD Million (2018-2023)
  • Table 15. Aesthetic Medicine Ambulatory Surgical Clinics , by Region USD Million (2018-2023)
  • Table 16. Aesthetic Medicine Dermatology Clinics , by Region USD Million (2018-2023)
  • Table 17. Aesthetic Medicine Others , by Region USD Million (2018-2023)
  • Table 18. Aesthetic Medicine: by Sales Channel(USD Million)
  • Table 19. Aesthetic Medicine Direct Sale , by Region USD Million (2018-2023)
  • Table 20. Aesthetic Medicine Indirect Sales {Pharmacies, E-commerce, and Others} , by Region USD Million (2018-2023)
  • Table 21. Aesthetic Medicine: by Procedure(USD Million)
  • Table 22. Aesthetic Medicine Surgical {Liposuction, Breast augmentation, Eyelid Surgery, Nose reshaping, and Others} , by Region USD Million (2018-2023)
  • Table 23. Aesthetic Medicine Non-Surgical {Chemical Peel, Botox injections, Soft Tissue Fillers, Laser Hair Removal, Microdermabrasion, and Others} , by Region USD Million (2018-2023)
  • Table 24. South America Aesthetic Medicine, by Country USD Million (2018-2023)
  • Table 25. South America Aesthetic Medicine, by Type USD Million (2018-2023)
  • Table 26. South America Aesthetic Medicine, by Application USD Million (2018-2023)
  • Table 27. South America Aesthetic Medicine, by End Use USD Million (2018-2023)
  • Table 28. South America Aesthetic Medicine, by Sales Channel USD Million (2018-2023)
  • Table 29. South America Aesthetic Medicine, by Procedure USD Million (2018-2023)
  • Table 30. Brazil Aesthetic Medicine, by Type USD Million (2018-2023)
  • Table 31. Brazil Aesthetic Medicine, by Application USD Million (2018-2023)
  • Table 32. Brazil Aesthetic Medicine, by End Use USD Million (2018-2023)
  • Table 33. Brazil Aesthetic Medicine, by Sales Channel USD Million (2018-2023)
  • Table 34. Brazil Aesthetic Medicine, by Procedure USD Million (2018-2023)
  • Table 35. Argentina Aesthetic Medicine, by Type USD Million (2018-2023)
  • Table 36. Argentina Aesthetic Medicine, by Application USD Million (2018-2023)
  • Table 37. Argentina Aesthetic Medicine, by End Use USD Million (2018-2023)
  • Table 38. Argentina Aesthetic Medicine, by Sales Channel USD Million (2018-2023)
  • Table 39. Argentina Aesthetic Medicine, by Procedure USD Million (2018-2023)
  • Table 40. Rest of South America Aesthetic Medicine, by Type USD Million (2018-2023)
  • Table 41. Rest of South America Aesthetic Medicine, by Application USD Million (2018-2023)
  • Table 42. Rest of South America Aesthetic Medicine, by End Use USD Million (2018-2023)
  • Table 43. Rest of South America Aesthetic Medicine, by Sales Channel USD Million (2018-2023)
  • Table 44. Rest of South America Aesthetic Medicine, by Procedure USD Million (2018-2023)
  • Table 45. Asia Pacific Aesthetic Medicine, by Country USD Million (2018-2023)
  • Table 46. Asia Pacific Aesthetic Medicine, by Type USD Million (2018-2023)
  • Table 47. Asia Pacific Aesthetic Medicine, by Application USD Million (2018-2023)
  • Table 48. Asia Pacific Aesthetic Medicine, by End Use USD Million (2018-2023)
  • Table 49. Asia Pacific Aesthetic Medicine, by Sales Channel USD Million (2018-2023)
  • Table 50. Asia Pacific Aesthetic Medicine, by Procedure USD Million (2018-2023)
  • Table 51. China Aesthetic Medicine, by Type USD Million (2018-2023)
  • Table 52. China Aesthetic Medicine, by Application USD Million (2018-2023)
  • Table 53. China Aesthetic Medicine, by End Use USD Million (2018-2023)
  • Table 54. China Aesthetic Medicine, by Sales Channel USD Million (2018-2023)
  • Table 55. China Aesthetic Medicine, by Procedure USD Million (2018-2023)
  • Table 56. Japan Aesthetic Medicine, by Type USD Million (2018-2023)
  • Table 57. Japan Aesthetic Medicine, by Application USD Million (2018-2023)
  • Table 58. Japan Aesthetic Medicine, by End Use USD Million (2018-2023)
  • Table 59. Japan Aesthetic Medicine, by Sales Channel USD Million (2018-2023)
  • Table 60. Japan Aesthetic Medicine, by Procedure USD Million (2018-2023)
  • Table 61. India Aesthetic Medicine, by Type USD Million (2018-2023)
  • Table 62. India Aesthetic Medicine, by Application USD Million (2018-2023)
  • Table 63. India Aesthetic Medicine, by End Use USD Million (2018-2023)
  • Table 64. India Aesthetic Medicine, by Sales Channel USD Million (2018-2023)
  • Table 65. India Aesthetic Medicine, by Procedure USD Million (2018-2023)
  • Table 66. South Korea Aesthetic Medicine, by Type USD Million (2018-2023)
  • Table 67. South Korea Aesthetic Medicine, by Application USD Million (2018-2023)
  • Table 68. South Korea Aesthetic Medicine, by End Use USD Million (2018-2023)
  • Table 69. South Korea Aesthetic Medicine, by Sales Channel USD Million (2018-2023)
  • Table 70. South Korea Aesthetic Medicine, by Procedure USD Million (2018-2023)
  • Table 71. Taiwan Aesthetic Medicine, by Type USD Million (2018-2023)
  • Table 72. Taiwan Aesthetic Medicine, by Application USD Million (2018-2023)
  • Table 73. Taiwan Aesthetic Medicine, by End Use USD Million (2018-2023)
  • Table 74. Taiwan Aesthetic Medicine, by Sales Channel USD Million (2018-2023)
  • Table 75. Taiwan Aesthetic Medicine, by Procedure USD Million (2018-2023)
  • Table 76. Australia Aesthetic Medicine, by Type USD Million (2018-2023)
  • Table 77. Australia Aesthetic Medicine, by Application USD Million (2018-2023)
  • Table 78. Australia Aesthetic Medicine, by End Use USD Million (2018-2023)
  • Table 79. Australia Aesthetic Medicine, by Sales Channel USD Million (2018-2023)
  • Table 80. Australia Aesthetic Medicine, by Procedure USD Million (2018-2023)
  • Table 81. Rest of Asia-Pacific Aesthetic Medicine, by Type USD Million (2018-2023)
  • Table 82. Rest of Asia-Pacific Aesthetic Medicine, by Application USD Million (2018-2023)
  • Table 83. Rest of Asia-Pacific Aesthetic Medicine, by End Use USD Million (2018-2023)
  • Table 84. Rest of Asia-Pacific Aesthetic Medicine, by Sales Channel USD Million (2018-2023)
  • Table 85. Rest of Asia-Pacific Aesthetic Medicine, by Procedure USD Million (2018-2023)
  • Table 86. Europe Aesthetic Medicine, by Country USD Million (2018-2023)
  • Table 87. Europe Aesthetic Medicine, by Type USD Million (2018-2023)
  • Table 88. Europe Aesthetic Medicine, by Application USD Million (2018-2023)
  • Table 89. Europe Aesthetic Medicine, by End Use USD Million (2018-2023)
  • Table 90. Europe Aesthetic Medicine, by Sales Channel USD Million (2018-2023)
  • Table 91. Europe Aesthetic Medicine, by Procedure USD Million (2018-2023)
  • Table 92. Germany Aesthetic Medicine, by Type USD Million (2018-2023)
  • Table 93. Germany Aesthetic Medicine, by Application USD Million (2018-2023)
  • Table 94. Germany Aesthetic Medicine, by End Use USD Million (2018-2023)
  • Table 95. Germany Aesthetic Medicine, by Sales Channel USD Million (2018-2023)
  • Table 96. Germany Aesthetic Medicine, by Procedure USD Million (2018-2023)
  • Table 97. France Aesthetic Medicine, by Type USD Million (2018-2023)
  • Table 98. France Aesthetic Medicine, by Application USD Million (2018-2023)
  • Table 99. France Aesthetic Medicine, by End Use USD Million (2018-2023)
  • Table 100. France Aesthetic Medicine, by Sales Channel USD Million (2018-2023)
  • Table 101. France Aesthetic Medicine, by Procedure USD Million (2018-2023)
  • Table 102. Italy Aesthetic Medicine, by Type USD Million (2018-2023)
  • Table 103. Italy Aesthetic Medicine, by Application USD Million (2018-2023)
  • Table 104. Italy Aesthetic Medicine, by End Use USD Million (2018-2023)
  • Table 105. Italy Aesthetic Medicine, by Sales Channel USD Million (2018-2023)
  • Table 106. Italy Aesthetic Medicine, by Procedure USD Million (2018-2023)
  • Table 107. United Kingdom Aesthetic Medicine, by Type USD Million (2018-2023)
  • Table 108. United Kingdom Aesthetic Medicine, by Application USD Million (2018-2023)
  • Table 109. United Kingdom Aesthetic Medicine, by End Use USD Million (2018-2023)
  • Table 110. United Kingdom Aesthetic Medicine, by Sales Channel USD Million (2018-2023)
  • Table 111. United Kingdom Aesthetic Medicine, by Procedure USD Million (2018-2023)
  • Table 112. Netherlands Aesthetic Medicine, by Type USD Million (2018-2023)
  • Table 113. Netherlands Aesthetic Medicine, by Application USD Million (2018-2023)
  • Table 114. Netherlands Aesthetic Medicine, by End Use USD Million (2018-2023)
  • Table 115. Netherlands Aesthetic Medicine, by Sales Channel USD Million (2018-2023)
  • Table 116. Netherlands Aesthetic Medicine, by Procedure USD Million (2018-2023)
  • Table 117. Rest of Europe Aesthetic Medicine, by Type USD Million (2018-2023)
  • Table 118. Rest of Europe Aesthetic Medicine, by Application USD Million (2018-2023)
  • Table 119. Rest of Europe Aesthetic Medicine, by End Use USD Million (2018-2023)
  • Table 120. Rest of Europe Aesthetic Medicine, by Sales Channel USD Million (2018-2023)
  • Table 121. Rest of Europe Aesthetic Medicine, by Procedure USD Million (2018-2023)
  • Table 122. MEA Aesthetic Medicine, by Country USD Million (2018-2023)
  • Table 123. MEA Aesthetic Medicine, by Type USD Million (2018-2023)
  • Table 124. MEA Aesthetic Medicine, by Application USD Million (2018-2023)
  • Table 125. MEA Aesthetic Medicine, by End Use USD Million (2018-2023)
  • Table 126. MEA Aesthetic Medicine, by Sales Channel USD Million (2018-2023)
  • Table 127. MEA Aesthetic Medicine, by Procedure USD Million (2018-2023)
  • Table 128. Middle East Aesthetic Medicine, by Type USD Million (2018-2023)
  • Table 129. Middle East Aesthetic Medicine, by Application USD Million (2018-2023)
  • Table 130. Middle East Aesthetic Medicine, by End Use USD Million (2018-2023)
  • Table 131. Middle East Aesthetic Medicine, by Sales Channel USD Million (2018-2023)
  • Table 132. Middle East Aesthetic Medicine, by Procedure USD Million (2018-2023)
  • Table 133. Africa Aesthetic Medicine, by Type USD Million (2018-2023)
  • Table 134. Africa Aesthetic Medicine, by Application USD Million (2018-2023)
  • Table 135. Africa Aesthetic Medicine, by End Use USD Million (2018-2023)
  • Table 136. Africa Aesthetic Medicine, by Sales Channel USD Million (2018-2023)
  • Table 137. Africa Aesthetic Medicine, by Procedure USD Million (2018-2023)
  • Table 138. North America Aesthetic Medicine, by Country USD Million (2018-2023)
  • Table 139. North America Aesthetic Medicine, by Type USD Million (2018-2023)
  • Table 140. North America Aesthetic Medicine, by Application USD Million (2018-2023)
  • Table 141. North America Aesthetic Medicine, by End Use USD Million (2018-2023)
  • Table 142. North America Aesthetic Medicine, by Sales Channel USD Million (2018-2023)
  • Table 143. North America Aesthetic Medicine, by Procedure USD Million (2018-2023)
  • Table 144. United States Aesthetic Medicine, by Type USD Million (2018-2023)
  • Table 145. United States Aesthetic Medicine, by Application USD Million (2018-2023)
  • Table 146. United States Aesthetic Medicine, by End Use USD Million (2018-2023)
  • Table 147. United States Aesthetic Medicine, by Sales Channel USD Million (2018-2023)
  • Table 148. United States Aesthetic Medicine, by Procedure USD Million (2018-2023)
  • Table 149. Canada Aesthetic Medicine, by Type USD Million (2018-2023)
  • Table 150. Canada Aesthetic Medicine, by Application USD Million (2018-2023)
  • Table 151. Canada Aesthetic Medicine, by End Use USD Million (2018-2023)
  • Table 152. Canada Aesthetic Medicine, by Sales Channel USD Million (2018-2023)
  • Table 153. Canada Aesthetic Medicine, by Procedure USD Million (2018-2023)
  • Table 154. Mexico Aesthetic Medicine, by Type USD Million (2018-2023)
  • Table 155. Mexico Aesthetic Medicine, by Application USD Million (2018-2023)
  • Table 156. Mexico Aesthetic Medicine, by End Use USD Million (2018-2023)
  • Table 157. Mexico Aesthetic Medicine, by Sales Channel USD Million (2018-2023)
  • Table 158. Mexico Aesthetic Medicine, by Procedure USD Million (2018-2023)
  • Table 159. Aesthetic Medicine Sales: by Type(K Units)
  • Table 160. Aesthetic Medicine Sales Injectable Fillers , by Region K Units (2018-2023)
  • Table 161. Aesthetic Medicine Sales Cream , by Region K Units (2018-2023)
  • Table 162. Aesthetic Medicine Sales Ointment , by Region K Units (2018-2023)
  • Table 163. Aesthetic Medicine Sales Capsules , by Region K Units (2018-2023)
  • Table 164. Aesthetic Medicine Sales Others , by Region K Units (2018-2023)
  • Table 165. Aesthetic Medicine Sales: by Application(K Units)
  • Table 166. Aesthetic Medicine Sales Instant Rejuvenation , by Region K Units (2018-2023)
  • Table 167. Aesthetic Medicine Sales Wrinkle Prevention , by Region K Units (2018-2023)
  • Table 168. Aesthetic Medicine Sales Weight Loss , by Region K Units (2018-2023)
  • Table 169. Aesthetic Medicine Sales Skin Tightening , by Region K Units (2018-2023)
  • Table 170. Aesthetic Medicine Sales Others , by Region K Units (2018-2023)
  • Table 171. Aesthetic Medicine Sales: by End Use(K Units)
  • Table 172. Aesthetic Medicine Sales Hospitals , by Region K Units (2018-2023)
  • Table 173. Aesthetic Medicine Sales Ambulatory Surgical Clinics , by Region K Units (2018-2023)
  • Table 174. Aesthetic Medicine Sales Dermatology Clinics , by Region K Units (2018-2023)
  • Table 175. Aesthetic Medicine Sales Others , by Region K Units (2018-2023)
  • Table 176. Aesthetic Medicine Sales: by Sales Channel(K Units)
  • Table 177. Aesthetic Medicine Sales Direct Sale , by Region K Units (2018-2023)
  • Table 178. Aesthetic Medicine Sales Indirect Sales {Pharmacies, E-commerce, and Others} , by Region K Units (2018-2023)
  • Table 179. Aesthetic Medicine Sales: by Procedure(K Units)
  • Table 180. Aesthetic Medicine Sales Surgical {Liposuction, Breast augmentation, Eyelid Surgery, Nose reshaping, and Others} , by Region K Units (2018-2023)
  • Table 181. Aesthetic Medicine Sales Non-Surgical {Chemical Peel, Botox injections, Soft Tissue Fillers, Laser Hair Removal, Microdermabrasion, and Others} , by Region K Units (2018-2023)
  • Table 182. South America Aesthetic Medicine Sales, by Country K Units (2018-2023)
  • Table 183. South America Aesthetic Medicine Sales, by Type K Units (2018-2023)
  • Table 184. South America Aesthetic Medicine Sales, by Application K Units (2018-2023)
  • Table 185. South America Aesthetic Medicine Sales, by End Use K Units (2018-2023)
  • Table 186. South America Aesthetic Medicine Sales, by Sales Channel K Units (2018-2023)
  • Table 187. South America Aesthetic Medicine Sales, by Procedure K Units (2018-2023)
  • Table 188. Brazil Aesthetic Medicine Sales, by Type K Units (2018-2023)
  • Table 189. Brazil Aesthetic Medicine Sales, by Application K Units (2018-2023)
  • Table 190. Brazil Aesthetic Medicine Sales, by End Use K Units (2018-2023)
  • Table 191. Brazil Aesthetic Medicine Sales, by Sales Channel K Units (2018-2023)
  • Table 192. Brazil Aesthetic Medicine Sales, by Procedure K Units (2018-2023)
  • Table 193. Argentina Aesthetic Medicine Sales, by Type K Units (2018-2023)
  • Table 194. Argentina Aesthetic Medicine Sales, by Application K Units (2018-2023)
  • Table 195. Argentina Aesthetic Medicine Sales, by End Use K Units (2018-2023)
  • Table 196. Argentina Aesthetic Medicine Sales, by Sales Channel K Units (2018-2023)
  • Table 197. Argentina Aesthetic Medicine Sales, by Procedure K Units (2018-2023)
  • Table 198. Rest of South America Aesthetic Medicine Sales, by Type K Units (2018-2023)
  • Table 199. Rest of South America Aesthetic Medicine Sales, by Application K Units (2018-2023)
  • Table 200. Rest of South America Aesthetic Medicine Sales, by End Use K Units (2018-2023)
  • Table 201. Rest of South America Aesthetic Medicine Sales, by Sales Channel K Units (2018-2023)
  • Table 202. Rest of South America Aesthetic Medicine Sales, by Procedure K Units (2018-2023)
  • Table 203. Asia Pacific Aesthetic Medicine Sales, by Country K Units (2018-2023)
  • Table 204. Asia Pacific Aesthetic Medicine Sales, by Type K Units (2018-2023)
  • Table 205. Asia Pacific Aesthetic Medicine Sales, by Application K Units (2018-2023)
  • Table 206. Asia Pacific Aesthetic Medicine Sales, by End Use K Units (2018-2023)
  • Table 207. Asia Pacific Aesthetic Medicine Sales, by Sales Channel K Units (2018-2023)
  • Table 208. Asia Pacific Aesthetic Medicine Sales, by Procedure K Units (2018-2023)
  • Table 209. China Aesthetic Medicine Sales, by Type K Units (2018-2023)
  • Table 210. China Aesthetic Medicine Sales, by Application K Units (2018-2023)
  • Table 211. China Aesthetic Medicine Sales, by End Use K Units (2018-2023)
  • Table 212. China Aesthetic Medicine Sales, by Sales Channel K Units (2018-2023)
  • Table 213. China Aesthetic Medicine Sales, by Procedure K Units (2018-2023)
  • Table 214. Japan Aesthetic Medicine Sales, by Type K Units (2018-2023)
  • Table 215. Japan Aesthetic Medicine Sales, by Application K Units (2018-2023)
  • Table 216. Japan Aesthetic Medicine Sales, by End Use K Units (2018-2023)
  • Table 217. Japan Aesthetic Medicine Sales, by Sales Channel K Units (2018-2023)
  • Table 218. Japan Aesthetic Medicine Sales, by Procedure K Units (2018-2023)
  • Table 219. India Aesthetic Medicine Sales, by Type K Units (2018-2023)
  • Table 220. India Aesthetic Medicine Sales, by Application K Units (2018-2023)
  • Table 221. India Aesthetic Medicine Sales, by End Use K Units (2018-2023)
  • Table 222. India Aesthetic Medicine Sales, by Sales Channel K Units (2018-2023)
  • Table 223. India Aesthetic Medicine Sales, by Procedure K Units (2018-2023)
  • Table 224. South Korea Aesthetic Medicine Sales, by Type K Units (2018-2023)
  • Table 225. South Korea Aesthetic Medicine Sales, by Application K Units (2018-2023)
  • Table 226. South Korea Aesthetic Medicine Sales, by End Use K Units (2018-2023)
  • Table 227. South Korea Aesthetic Medicine Sales, by Sales Channel K Units (2018-2023)
  • Table 228. South Korea Aesthetic Medicine Sales, by Procedure K Units (2018-2023)
  • Table 229. Taiwan Aesthetic Medicine Sales, by Type K Units (2018-2023)
  • Table 230. Taiwan Aesthetic Medicine Sales, by Application K Units (2018-2023)
  • Table 231. Taiwan Aesthetic Medicine Sales, by End Use K Units (2018-2023)
  • Table 232. Taiwan Aesthetic Medicine Sales, by Sales Channel K Units (2018-2023)
  • Table 233. Taiwan Aesthetic Medicine Sales, by Procedure K Units (2018-2023)
  • Table 234. Australia Aesthetic Medicine Sales, by Type K Units (2018-2023)
  • Table 235. Australia Aesthetic Medicine Sales, by Application K Units (2018-2023)
  • Table 236. Australia Aesthetic Medicine Sales, by End Use K Units (2018-2023)
  • Table 237. Australia Aesthetic Medicine Sales, by Sales Channel K Units (2018-2023)
  • Table 238. Australia Aesthetic Medicine Sales, by Procedure K Units (2018-2023)
  • Table 239. Rest of Asia-Pacific Aesthetic Medicine Sales, by Type K Units (2018-2023)
  • Table 240. Rest of Asia-Pacific Aesthetic Medicine Sales, by Application K Units (2018-2023)
  • Table 241. Rest of Asia-Pacific Aesthetic Medicine Sales, by End Use K Units (2018-2023)
  • Table 242. Rest of Asia-Pacific Aesthetic Medicine Sales, by Sales Channel K Units (2018-2023)
  • Table 243. Rest of Asia-Pacific Aesthetic Medicine Sales, by Procedure K Units (2018-2023)
  • Table 244. Europe Aesthetic Medicine Sales, by Country K Units (2018-2023)
  • Table 245. Europe Aesthetic Medicine Sales, by Type K Units (2018-2023)
  • Table 246. Europe Aesthetic Medicine Sales, by Application K Units (2018-2023)
  • Table 247. Europe Aesthetic Medicine Sales, by End Use K Units (2018-2023)
  • Table 248. Europe Aesthetic Medicine Sales, by Sales Channel K Units (2018-2023)
  • Table 249. Europe Aesthetic Medicine Sales, by Procedure K Units (2018-2023)
  • Table 250. Germany Aesthetic Medicine Sales, by Type K Units (2018-2023)
  • Table 251. Germany Aesthetic Medicine Sales, by Application K Units (2018-2023)
  • Table 252. Germany Aesthetic Medicine Sales, by End Use K Units (2018-2023)
  • Table 253. Germany Aesthetic Medicine Sales, by Sales Channel K Units (2018-2023)
  • Table 254. Germany Aesthetic Medicine Sales, by Procedure K Units (2018-2023)
  • Table 255. France Aesthetic Medicine Sales, by Type K Units (2018-2023)
  • Table 256. France Aesthetic Medicine Sales, by Application K Units (2018-2023)
  • Table 257. France Aesthetic Medicine Sales, by End Use K Units (2018-2023)
  • Table 258. France Aesthetic Medicine Sales, by Sales Channel K Units (2018-2023)
  • Table 259. France Aesthetic Medicine Sales, by Procedure K Units (2018-2023)
  • Table 260. Italy Aesthetic Medicine Sales, by Type K Units (2018-2023)
  • Table 261. Italy Aesthetic Medicine Sales, by Application K Units (2018-2023)
  • Table 262. Italy Aesthetic Medicine Sales, by End Use K Units (2018-2023)
  • Table 263. Italy Aesthetic Medicine Sales, by Sales Channel K Units (2018-2023)
  • Table 264. Italy Aesthetic Medicine Sales, by Procedure K Units (2018-2023)
  • Table 265. United Kingdom Aesthetic Medicine Sales, by Type K Units (2018-2023)
  • Table 266. United Kingdom Aesthetic Medicine Sales, by Application K Units (2018-2023)
  • Table 267. United Kingdom Aesthetic Medicine Sales, by End Use K Units (2018-2023)
  • Table 268. United Kingdom Aesthetic Medicine Sales, by Sales Channel K Units (2018-2023)
  • Table 269. United Kingdom Aesthetic Medicine Sales, by Procedure K Units (2018-2023)
  • Table 270. Netherlands Aesthetic Medicine Sales, by Type K Units (2018-2023)
  • Table 271. Netherlands Aesthetic Medicine Sales, by Application K Units (2018-2023)
  • Table 272. Netherlands Aesthetic Medicine Sales, by End Use K Units (2018-2023)
  • Table 273. Netherlands Aesthetic Medicine Sales, by Sales Channel K Units (2018-2023)
  • Table 274. Netherlands Aesthetic Medicine Sales, by Procedure K Units (2018-2023)
  • Table 275. Rest of Europe Aesthetic Medicine Sales, by Type K Units (2018-2023)
  • Table 276. Rest of Europe Aesthetic Medicine Sales, by Application K Units (2018-2023)
  • Table 277. Rest of Europe Aesthetic Medicine Sales, by End Use K Units (2018-2023)
  • Table 278. Rest of Europe Aesthetic Medicine Sales, by Sales Channel K Units (2018-2023)
  • Table 279. Rest of Europe Aesthetic Medicine Sales, by Procedure K Units (2018-2023)
  • Table 280. MEA Aesthetic Medicine Sales, by Country K Units (2018-2023)
  • Table 281. MEA Aesthetic Medicine Sales, by Type K Units (2018-2023)
  • Table 282. MEA Aesthetic Medicine Sales, by Application K Units (2018-2023)
  • Table 283. MEA Aesthetic Medicine Sales, by End Use K Units (2018-2023)
  • Table 284. MEA Aesthetic Medicine Sales, by Sales Channel K Units (2018-2023)
  • Table 285. MEA Aesthetic Medicine Sales, by Procedure K Units (2018-2023)
  • Table 286. Middle East Aesthetic Medicine Sales, by Type K Units (2018-2023)
  • Table 287. Middle East Aesthetic Medicine Sales, by Application K Units (2018-2023)
  • Table 288. Middle East Aesthetic Medicine Sales, by End Use K Units (2018-2023)
  • Table 289. Middle East Aesthetic Medicine Sales, by Sales Channel K Units (2018-2023)
  • Table 290. Middle East Aesthetic Medicine Sales, by Procedure K Units (2018-2023)
  • Table 291. Africa Aesthetic Medicine Sales, by Type K Units (2018-2023)
  • Table 292. Africa Aesthetic Medicine Sales, by Application K Units (2018-2023)
  • Table 293. Africa Aesthetic Medicine Sales, by End Use K Units (2018-2023)
  • Table 294. Africa Aesthetic Medicine Sales, by Sales Channel K Units (2018-2023)
  • Table 295. Africa Aesthetic Medicine Sales, by Procedure K Units (2018-2023)
  • Table 296. North America Aesthetic Medicine Sales, by Country K Units (2018-2023)
  • Table 297. North America Aesthetic Medicine Sales, by Type K Units (2018-2023)
  • Table 298. North America Aesthetic Medicine Sales, by Application K Units (2018-2023)
  • Table 299. North America Aesthetic Medicine Sales, by End Use K Units (2018-2023)
  • Table 300. North America Aesthetic Medicine Sales, by Sales Channel K Units (2018-2023)
  • Table 301. North America Aesthetic Medicine Sales, by Procedure K Units (2018-2023)
  • Table 302. United States Aesthetic Medicine Sales, by Type K Units (2018-2023)
  • Table 303. United States Aesthetic Medicine Sales, by Application K Units (2018-2023)
  • Table 304. United States Aesthetic Medicine Sales, by End Use K Units (2018-2023)
  • Table 305. United States Aesthetic Medicine Sales, by Sales Channel K Units (2018-2023)
  • Table 306. United States Aesthetic Medicine Sales, by Procedure K Units (2018-2023)
  • Table 307. Canada Aesthetic Medicine Sales, by Type K Units (2018-2023)
  • Table 308. Canada Aesthetic Medicine Sales, by Application K Units (2018-2023)
  • Table 309. Canada Aesthetic Medicine Sales, by End Use K Units (2018-2023)
  • Table 310. Canada Aesthetic Medicine Sales, by Sales Channel K Units (2018-2023)
  • Table 311. Canada Aesthetic Medicine Sales, by Procedure K Units (2018-2023)
  • Table 312. Mexico Aesthetic Medicine Sales, by Type K Units (2018-2023)
  • Table 313. Mexico Aesthetic Medicine Sales, by Application K Units (2018-2023)
  • Table 314. Mexico Aesthetic Medicine Sales, by End Use K Units (2018-2023)
  • Table 315. Mexico Aesthetic Medicine Sales, by Sales Channel K Units (2018-2023)
  • Table 316. Mexico Aesthetic Medicine Sales, by Procedure K Units (2018-2023)
  • Table 317. Aesthetic Medicine: by Type(USD/Units)
  • Table 318. Company Basic Information, Sales Area and Its Competitors
  • Table 319. Company Basic Information, Sales Area and Its Competitors
  • Table 320. Company Basic Information, Sales Area and Its Competitors
  • Table 321. Company Basic Information, Sales Area and Its Competitors
  • Table 322. Company Basic Information, Sales Area and Its Competitors
  • Table 323. Company Basic Information, Sales Area and Its Competitors
  • Table 324. Company Basic Information, Sales Area and Its Competitors
  • Table 325. Company Basic Information, Sales Area and Its Competitors
  • Table 326. Company Basic Information, Sales Area and Its Competitors
  • Table 327. Company Basic Information, Sales Area and Its Competitors
  • Table 328. Company Basic Information, Sales Area and Its Competitors
  • Table 329. Aesthetic Medicine: by Type(USD Million)
  • Table 330. Aesthetic Medicine Injectable Fillers , by Region USD Million (2025-2030)
  • Table 331. Aesthetic Medicine Cream , by Region USD Million (2025-2030)
  • Table 332. Aesthetic Medicine Ointment , by Region USD Million (2025-2030)
  • Table 333. Aesthetic Medicine Capsules , by Region USD Million (2025-2030)
  • Table 334. Aesthetic Medicine Others , by Region USD Million (2025-2030)
  • Table 335. Aesthetic Medicine: by Application(USD Million)
  • Table 336. Aesthetic Medicine Instant Rejuvenation , by Region USD Million (2025-2030)
  • Table 337. Aesthetic Medicine Wrinkle Prevention , by Region USD Million (2025-2030)
  • Table 338. Aesthetic Medicine Weight Loss , by Region USD Million (2025-2030)
  • Table 339. Aesthetic Medicine Skin Tightening , by Region USD Million (2025-2030)
  • Table 340. Aesthetic Medicine Others , by Region USD Million (2025-2030)
  • Table 341. Aesthetic Medicine: by End Use(USD Million)
  • Table 342. Aesthetic Medicine Hospitals , by Region USD Million (2025-2030)
  • Table 343. Aesthetic Medicine Ambulatory Surgical Clinics , by Region USD Million (2025-2030)
  • Table 344. Aesthetic Medicine Dermatology Clinics , by Region USD Million (2025-2030)
  • Table 345. Aesthetic Medicine Others , by Region USD Million (2025-2030)
  • Table 346. Aesthetic Medicine: by Sales Channel(USD Million)
  • Table 347. Aesthetic Medicine Direct Sale , by Region USD Million (2025-2030)
  • Table 348. Aesthetic Medicine Indirect Sales {Pharmacies, E-commerce, and Others} , by Region USD Million (2025-2030)
  • Table 349. Aesthetic Medicine: by Procedure(USD Million)
  • Table 350. Aesthetic Medicine Surgical {Liposuction, Breast augmentation, Eyelid Surgery, Nose reshaping, and Others} , by Region USD Million (2025-2030)
  • Table 351. Aesthetic Medicine Non-Surgical {Chemical Peel, Botox injections, Soft Tissue Fillers, Laser Hair Removal, Microdermabrasion, and Others} , by Region USD Million (2025-2030)
  • Table 352. South America Aesthetic Medicine, by Country USD Million (2025-2030)
  • Table 353. South America Aesthetic Medicine, by Type USD Million (2025-2030)
  • Table 354. South America Aesthetic Medicine, by Application USD Million (2025-2030)
  • Table 355. South America Aesthetic Medicine, by End Use USD Million (2025-2030)
  • Table 356. South America Aesthetic Medicine, by Sales Channel USD Million (2025-2030)
  • Table 357. South America Aesthetic Medicine, by Procedure USD Million (2025-2030)
  • Table 358. Brazil Aesthetic Medicine, by Type USD Million (2025-2030)
  • Table 359. Brazil Aesthetic Medicine, by Application USD Million (2025-2030)
  • Table 360. Brazil Aesthetic Medicine, by End Use USD Million (2025-2030)
  • Table 361. Brazil Aesthetic Medicine, by Sales Channel USD Million (2025-2030)
  • Table 362. Brazil Aesthetic Medicine, by Procedure USD Million (2025-2030)
  • Table 363. Argentina Aesthetic Medicine, by Type USD Million (2025-2030)
  • Table 364. Argentina Aesthetic Medicine, by Application USD Million (2025-2030)
  • Table 365. Argentina Aesthetic Medicine, by End Use USD Million (2025-2030)
  • Table 366. Argentina Aesthetic Medicine, by Sales Channel USD Million (2025-2030)
  • Table 367. Argentina Aesthetic Medicine, by Procedure USD Million (2025-2030)
  • Table 368. Rest of South America Aesthetic Medicine, by Type USD Million (2025-2030)
  • Table 369. Rest of South America Aesthetic Medicine, by Application USD Million (2025-2030)
  • Table 370. Rest of South America Aesthetic Medicine, by End Use USD Million (2025-2030)
  • Table 371. Rest of South America Aesthetic Medicine, by Sales Channel USD Million (2025-2030)
  • Table 372. Rest of South America Aesthetic Medicine, by Procedure USD Million (2025-2030)
  • Table 373. Asia Pacific Aesthetic Medicine, by Country USD Million (2025-2030)
  • Table 374. Asia Pacific Aesthetic Medicine, by Type USD Million (2025-2030)
  • Table 375. Asia Pacific Aesthetic Medicine, by Application USD Million (2025-2030)
  • Table 376. Asia Pacific Aesthetic Medicine, by End Use USD Million (2025-2030)
  • Table 377. Asia Pacific Aesthetic Medicine, by Sales Channel USD Million (2025-2030)
  • Table 378. Asia Pacific Aesthetic Medicine, by Procedure USD Million (2025-2030)
  • Table 379. China Aesthetic Medicine, by Type USD Million (2025-2030)
  • Table 380. China Aesthetic Medicine, by Application USD Million (2025-2030)
  • Table 381. China Aesthetic Medicine, by End Use USD Million (2025-2030)
  • Table 382. China Aesthetic Medicine, by Sales Channel USD Million (2025-2030)
  • Table 383. China Aesthetic Medicine, by Procedure USD Million (2025-2030)
  • Table 384. Japan Aesthetic Medicine, by Type USD Million (2025-2030)
  • Table 385. Japan Aesthetic Medicine, by Application USD Million (2025-2030)
  • Table 386. Japan Aesthetic Medicine, by End Use USD Million (2025-2030)
  • Table 387. Japan Aesthetic Medicine, by Sales Channel USD Million (2025-2030)
  • Table 388. Japan Aesthetic Medicine, by Procedure USD Million (2025-2030)
  • Table 389. India Aesthetic Medicine, by Type USD Million (2025-2030)
  • Table 390. India Aesthetic Medicine, by Application USD Million (2025-2030)
  • Table 391. India Aesthetic Medicine, by End Use USD Million (2025-2030)
  • Table 392. India Aesthetic Medicine, by Sales Channel USD Million (2025-2030)
  • Table 393. India Aesthetic Medicine, by Procedure USD Million (2025-2030)
  • Table 394. South Korea Aesthetic Medicine, by Type USD Million (2025-2030)
  • Table 395. South Korea Aesthetic Medicine, by Application USD Million (2025-2030)
  • Table 396. South Korea Aesthetic Medicine, by End Use USD Million (2025-2030)
  • Table 397. South Korea Aesthetic Medicine, by Sales Channel USD Million (2025-2030)
  • Table 398. South Korea Aesthetic Medicine, by Procedure USD Million (2025-2030)
  • Table 399. Taiwan Aesthetic Medicine, by Type USD Million (2025-2030)
  • Table 400. Taiwan Aesthetic Medicine, by Application USD Million (2025-2030)
  • Table 401. Taiwan Aesthetic Medicine, by End Use USD Million (2025-2030)
  • Table 402. Taiwan Aesthetic Medicine, by Sales Channel USD Million (2025-2030)
  • Table 403. Taiwan Aesthetic Medicine, by Procedure USD Million (2025-2030)
  • Table 404. Australia Aesthetic Medicine, by Type USD Million (2025-2030)
  • Table 405. Australia Aesthetic Medicine, by Application USD Million (2025-2030)
  • Table 406. Australia Aesthetic Medicine, by End Use USD Million (2025-2030)
  • Table 407. Australia Aesthetic Medicine, by Sales Channel USD Million (2025-2030)
  • Table 408. Australia Aesthetic Medicine, by Procedure USD Million (2025-2030)
  • Table 409. Rest of Asia-Pacific Aesthetic Medicine, by Type USD Million (2025-2030)
  • Table 410. Rest of Asia-Pacific Aesthetic Medicine, by Application USD Million (2025-2030)
  • Table 411. Rest of Asia-Pacific Aesthetic Medicine, by End Use USD Million (2025-2030)
  • Table 412. Rest of Asia-Pacific Aesthetic Medicine, by Sales Channel USD Million (2025-2030)
  • Table 413. Rest of Asia-Pacific Aesthetic Medicine, by Procedure USD Million (2025-2030)
  • Table 414. Europe Aesthetic Medicine, by Country USD Million (2025-2030)
  • Table 415. Europe Aesthetic Medicine, by Type USD Million (2025-2030)
  • Table 416. Europe Aesthetic Medicine, by Application USD Million (2025-2030)
  • Table 417. Europe Aesthetic Medicine, by End Use USD Million (2025-2030)
  • Table 418. Europe Aesthetic Medicine, by Sales Channel USD Million (2025-2030)
  • Table 419. Europe Aesthetic Medicine, by Procedure USD Million (2025-2030)
  • Table 420. Germany Aesthetic Medicine, by Type USD Million (2025-2030)
  • Table 421. Germany Aesthetic Medicine, by Application USD Million (2025-2030)
  • Table 422. Germany Aesthetic Medicine, by End Use USD Million (2025-2030)
  • Table 423. Germany Aesthetic Medicine, by Sales Channel USD Million (2025-2030)
  • Table 424. Germany Aesthetic Medicine, by Procedure USD Million (2025-2030)
  • Table 425. France Aesthetic Medicine, by Type USD Million (2025-2030)
  • Table 426. France Aesthetic Medicine, by Application USD Million (2025-2030)
  • Table 427. France Aesthetic Medicine, by End Use USD Million (2025-2030)
  • Table 428. France Aesthetic Medicine, by Sales Channel USD Million (2025-2030)
  • Table 429. France Aesthetic Medicine, by Procedure USD Million (2025-2030)
  • Table 430. Italy Aesthetic Medicine, by Type USD Million (2025-2030)
  • Table 431. Italy Aesthetic Medicine, by Application USD Million (2025-2030)
  • Table 432. Italy Aesthetic Medicine, by End Use USD Million (2025-2030)
  • Table 433. Italy Aesthetic Medicine, by Sales Channel USD Million (2025-2030)
  • Table 434. Italy Aesthetic Medicine, by Procedure USD Million (2025-2030)
  • Table 435. United Kingdom Aesthetic Medicine, by Type USD Million (2025-2030)
  • Table 436. United Kingdom Aesthetic Medicine, by Application USD Million (2025-2030)
  • Table 437. United Kingdom Aesthetic Medicine, by End Use USD Million (2025-2030)
  • Table 438. United Kingdom Aesthetic Medicine, by Sales Channel USD Million (2025-2030)
  • Table 439. United Kingdom Aesthetic Medicine, by Procedure USD Million (2025-2030)
  • Table 440. Netherlands Aesthetic Medicine, by Type USD Million (2025-2030)
  • Table 441. Netherlands Aesthetic Medicine, by Application USD Million (2025-2030)
  • Table 442. Netherlands Aesthetic Medicine, by End Use USD Million (2025-2030)
  • Table 443. Netherlands Aesthetic Medicine, by Sales Channel USD Million (2025-2030)
  • Table 444. Netherlands Aesthetic Medicine, by Procedure USD Million (2025-2030)
  • Table 445. Rest of Europe Aesthetic Medicine, by Type USD Million (2025-2030)
  • Table 446. Rest of Europe Aesthetic Medicine, by Application USD Million (2025-2030)
  • Table 447. Rest of Europe Aesthetic Medicine, by End Use USD Million (2025-2030)
  • Table 448. Rest of Europe Aesthetic Medicine, by Sales Channel USD Million (2025-2030)
  • Table 449. Rest of Europe Aesthetic Medicine, by Procedure USD Million (2025-2030)
  • Table 450. MEA Aesthetic Medicine, by Country USD Million (2025-2030)
  • Table 451. MEA Aesthetic Medicine, by Type USD Million (2025-2030)
  • Table 452. MEA Aesthetic Medicine, by Application USD Million (2025-2030)
  • Table 453. MEA Aesthetic Medicine, by End Use USD Million (2025-2030)
  • Table 454. MEA Aesthetic Medicine, by Sales Channel USD Million (2025-2030)
  • Table 455. MEA Aesthetic Medicine, by Procedure USD Million (2025-2030)
  • Table 456. Middle East Aesthetic Medicine, by Type USD Million (2025-2030)
  • Table 457. Middle East Aesthetic Medicine, by Application USD Million (2025-2030)
  • Table 458. Middle East Aesthetic Medicine, by End Use USD Million (2025-2030)
  • Table 459. Middle East Aesthetic Medicine, by Sales Channel USD Million (2025-2030)
  • Table 460. Middle East Aesthetic Medicine, by Procedure USD Million (2025-2030)
  • Table 461. Africa Aesthetic Medicine, by Type USD Million (2025-2030)
  • Table 462. Africa Aesthetic Medicine, by Application USD Million (2025-2030)
  • Table 463. Africa Aesthetic Medicine, by End Use USD Million (2025-2030)
  • Table 464. Africa Aesthetic Medicine, by Sales Channel USD Million (2025-2030)
  • Table 465. Africa Aesthetic Medicine, by Procedure USD Million (2025-2030)
  • Table 466. North America Aesthetic Medicine, by Country USD Million (2025-2030)
  • Table 467. North America Aesthetic Medicine, by Type USD Million (2025-2030)
  • Table 468. North America Aesthetic Medicine, by Application USD Million (2025-2030)
  • Table 469. North America Aesthetic Medicine, by End Use USD Million (2025-2030)
  • Table 470. North America Aesthetic Medicine, by Sales Channel USD Million (2025-2030)
  • Table 471. North America Aesthetic Medicine, by Procedure USD Million (2025-2030)
  • Table 472. United States Aesthetic Medicine, by Type USD Million (2025-2030)
  • Table 473. United States Aesthetic Medicine, by Application USD Million (2025-2030)
  • Table 474. United States Aesthetic Medicine, by End Use USD Million (2025-2030)
  • Table 475. United States Aesthetic Medicine, by Sales Channel USD Million (2025-2030)
  • Table 476. United States Aesthetic Medicine, by Procedure USD Million (2025-2030)
  • Table 477. Canada Aesthetic Medicine, by Type USD Million (2025-2030)
  • Table 478. Canada Aesthetic Medicine, by Application USD Million (2025-2030)
  • Table 479. Canada Aesthetic Medicine, by End Use USD Million (2025-2030)
  • Table 480. Canada Aesthetic Medicine, by Sales Channel USD Million (2025-2030)
  • Table 481. Canada Aesthetic Medicine, by Procedure USD Million (2025-2030)
  • Table 482. Mexico Aesthetic Medicine, by Type USD Million (2025-2030)
  • Table 483. Mexico Aesthetic Medicine, by Application USD Million (2025-2030)
  • Table 484. Mexico Aesthetic Medicine, by End Use USD Million (2025-2030)
  • Table 485. Mexico Aesthetic Medicine, by Sales Channel USD Million (2025-2030)
  • Table 486. Mexico Aesthetic Medicine, by Procedure USD Million (2025-2030)
  • Table 487. Aesthetic Medicine Sales: by Type(K Units)
  • Table 488. Aesthetic Medicine Sales Injectable Fillers , by Region K Units (2025-2030)
  • Table 489. Aesthetic Medicine Sales Cream , by Region K Units (2025-2030)
  • Table 490. Aesthetic Medicine Sales Ointment , by Region K Units (2025-2030)
  • Table 491. Aesthetic Medicine Sales Capsules , by Region K Units (2025-2030)
  • Table 492. Aesthetic Medicine Sales Others , by Region K Units (2025-2030)
  • Table 493. Aesthetic Medicine Sales: by Application(K Units)
  • Table 494. Aesthetic Medicine Sales Instant Rejuvenation , by Region K Units (2025-2030)
  • Table 495. Aesthetic Medicine Sales Wrinkle Prevention , by Region K Units (2025-2030)
  • Table 496. Aesthetic Medicine Sales Weight Loss , by Region K Units (2025-2030)
  • Table 497. Aesthetic Medicine Sales Skin Tightening , by Region K Units (2025-2030)
  • Table 498. Aesthetic Medicine Sales Others , by Region K Units (2025-2030)
  • Table 499. Aesthetic Medicine Sales: by End Use(K Units)
  • Table 500. Aesthetic Medicine Sales Hospitals , by Region K Units (2025-2030)
  • Table 501. Aesthetic Medicine Sales Ambulatory Surgical Clinics , by Region K Units (2025-2030)
  • Table 502. Aesthetic Medicine Sales Dermatology Clinics , by Region K Units (2025-2030)
  • Table 503. Aesthetic Medicine Sales Others , by Region K Units (2025-2030)
  • Table 504. Aesthetic Medicine Sales: by Sales Channel(K Units)
  • Table 505. Aesthetic Medicine Sales Direct Sale , by Region K Units (2025-2030)
  • Table 506. Aesthetic Medicine Sales Indirect Sales {Pharmacies, E-commerce, and Others} , by Region K Units (2025-2030)
  • Table 507. Aesthetic Medicine Sales: by Procedure(K Units)
  • Table 508. Aesthetic Medicine Sales Surgical {Liposuction, Breast augmentation, Eyelid Surgery, Nose reshaping, and Others} , by Region K Units (2025-2030)
  • Table 509. Aesthetic Medicine Sales Non-Surgical {Chemical Peel, Botox injections, Soft Tissue Fillers, Laser Hair Removal, Microdermabrasion, and Others} , by Region K Units (2025-2030)
  • Table 510. South America Aesthetic Medicine Sales, by Country K Units (2025-2030)
  • Table 511. South America Aesthetic Medicine Sales, by Type K Units (2025-2030)
  • Table 512. South America Aesthetic Medicine Sales, by Application K Units (2025-2030)
  • Table 513. South America Aesthetic Medicine Sales, by End Use K Units (2025-2030)
  • Table 514. South America Aesthetic Medicine Sales, by Sales Channel K Units (2025-2030)
  • Table 515. South America Aesthetic Medicine Sales, by Procedure K Units (2025-2030)
  • Table 516. Brazil Aesthetic Medicine Sales, by Type K Units (2025-2030)
  • Table 517. Brazil Aesthetic Medicine Sales, by Application K Units (2025-2030)
  • Table 518. Brazil Aesthetic Medicine Sales, by End Use K Units (2025-2030)
  • Table 519. Brazil Aesthetic Medicine Sales, by Sales Channel K Units (2025-2030)
  • Table 520. Brazil Aesthetic Medicine Sales, by Procedure K Units (2025-2030)
  • Table 521. Argentina Aesthetic Medicine Sales, by Type K Units (2025-2030)
  • Table 522. Argentina Aesthetic Medicine Sales, by Application K Units (2025-2030)
  • Table 523. Argentina Aesthetic Medicine Sales, by End Use K Units (2025-2030)
  • Table 524. Argentina Aesthetic Medicine Sales, by Sales Channel K Units (2025-2030)
  • Table 525. Argentina Aesthetic Medicine Sales, by Procedure K Units (2025-2030)
  • Table 526. Rest of South America Aesthetic Medicine Sales, by Type K Units (2025-2030)
  • Table 527. Rest of South America Aesthetic Medicine Sales, by Application K Units (2025-2030)
  • Table 528. Rest of South America Aesthetic Medicine Sales, by End Use K Units (2025-2030)
  • Table 529. Rest of South America Aesthetic Medicine Sales, by Sales Channel K Units (2025-2030)
  • Table 530. Rest of South America Aesthetic Medicine Sales, by Procedure K Units (2025-2030)
  • Table 531. Asia Pacific Aesthetic Medicine Sales, by Country K Units (2025-2030)
  • Table 532. Asia Pacific Aesthetic Medicine Sales, by Type K Units (2025-2030)
  • Table 533. Asia Pacific Aesthetic Medicine Sales, by Application K Units (2025-2030)
  • Table 534. Asia Pacific Aesthetic Medicine Sales, by End Use K Units (2025-2030)
  • Table 535. Asia Pacific Aesthetic Medicine Sales, by Sales Channel K Units (2025-2030)
  • Table 536. Asia Pacific Aesthetic Medicine Sales, by Procedure K Units (2025-2030)
  • Table 537. China Aesthetic Medicine Sales, by Type K Units (2025-2030)
  • Table 538. China Aesthetic Medicine Sales, by Application K Units (2025-2030)
  • Table 539. China Aesthetic Medicine Sales, by End Use K Units (2025-2030)
  • Table 540. China Aesthetic Medicine Sales, by Sales Channel K Units (2025-2030)
  • Table 541. China Aesthetic Medicine Sales, by Procedure K Units (2025-2030)
  • Table 542. Japan Aesthetic Medicine Sales, by Type K Units (2025-2030)
  • Table 543. Japan Aesthetic Medicine Sales, by Application K Units (2025-2030)
  • Table 544. Japan Aesthetic Medicine Sales, by End Use K Units (2025-2030)
  • Table 545. Japan Aesthetic Medicine Sales, by Sales Channel K Units (2025-2030)
  • Table 546. Japan Aesthetic Medicine Sales, by Procedure K Units (2025-2030)
  • Table 547. India Aesthetic Medicine Sales, by Type K Units (2025-2030)
  • Table 548. India Aesthetic Medicine Sales, by Application K Units (2025-2030)
  • Table 549. India Aesthetic Medicine Sales, by End Use K Units (2025-2030)
  • Table 550. India Aesthetic Medicine Sales, by Sales Channel K Units (2025-2030)
  • Table 551. India Aesthetic Medicine Sales, by Procedure K Units (2025-2030)
  • Table 552. South Korea Aesthetic Medicine Sales, by Type K Units (2025-2030)
  • Table 553. South Korea Aesthetic Medicine Sales, by Application K Units (2025-2030)
  • Table 554. South Korea Aesthetic Medicine Sales, by End Use K Units (2025-2030)
  • Table 555. South Korea Aesthetic Medicine Sales, by Sales Channel K Units (2025-2030)
  • Table 556. South Korea Aesthetic Medicine Sales, by Procedure K Units (2025-2030)
  • Table 557. Taiwan Aesthetic Medicine Sales, by Type K Units (2025-2030)
  • Table 558. Taiwan Aesthetic Medicine Sales, by Application K Units (2025-2030)
  • Table 559. Taiwan Aesthetic Medicine Sales, by End Use K Units (2025-2030)
  • Table 560. Taiwan Aesthetic Medicine Sales, by Sales Channel K Units (2025-2030)
  • Table 561. Taiwan Aesthetic Medicine Sales, by Procedure K Units (2025-2030)
  • Table 562. Australia Aesthetic Medicine Sales, by Type K Units (2025-2030)
  • Table 563. Australia Aesthetic Medicine Sales, by Application K Units (2025-2030)
  • Table 564. Australia Aesthetic Medicine Sales, by End Use K Units (2025-2030)
  • Table 565. Australia Aesthetic Medicine Sales, by Sales Channel K Units (2025-2030)
  • Table 566. Australia Aesthetic Medicine Sales, by Procedure K Units (2025-2030)
  • Table 567. Rest of Asia-Pacific Aesthetic Medicine Sales, by Type K Units (2025-2030)
  • Table 568. Rest of Asia-Pacific Aesthetic Medicine Sales, by Application K Units (2025-2030)
  • Table 569. Rest of Asia-Pacific Aesthetic Medicine Sales, by End Use K Units (2025-2030)
  • Table 570. Rest of Asia-Pacific Aesthetic Medicine Sales, by Sales Channel K Units (2025-2030)
  • Table 571. Rest of Asia-Pacific Aesthetic Medicine Sales, by Procedure K Units (2025-2030)
  • Table 572. Europe Aesthetic Medicine Sales, by Country K Units (2025-2030)
  • Table 573. Europe Aesthetic Medicine Sales, by Type K Units (2025-2030)
  • Table 574. Europe Aesthetic Medicine Sales, by Application K Units (2025-2030)
  • Table 575. Europe Aesthetic Medicine Sales, by End Use K Units (2025-2030)
  • Table 576. Europe Aesthetic Medicine Sales, by Sales Channel K Units (2025-2030)
  • Table 577. Europe Aesthetic Medicine Sales, by Procedure K Units (2025-2030)
  • Table 578. Germany Aesthetic Medicine Sales, by Type K Units (2025-2030)
  • Table 579. Germany Aesthetic Medicine Sales, by Application K Units (2025-2030)
  • Table 580. Germany Aesthetic Medicine Sales, by End Use K Units (2025-2030)
  • Table 581. Germany Aesthetic Medicine Sales, by Sales Channel K Units (2025-2030)
  • Table 582. Germany Aesthetic Medicine Sales, by Procedure K Units (2025-2030)
  • Table 583. France Aesthetic Medicine Sales, by Type K Units (2025-2030)
  • Table 584. France Aesthetic Medicine Sales, by Application K Units (2025-2030)
  • Table 585. France Aesthetic Medicine Sales, by End Use K Units (2025-2030)
  • Table 586. France Aesthetic Medicine Sales, by Sales Channel K Units (2025-2030)
  • Table 587. France Aesthetic Medicine Sales, by Procedure K Units (2025-2030)
  • Table 588. Italy Aesthetic Medicine Sales, by Type K Units (2025-2030)
  • Table 589. Italy Aesthetic Medicine Sales, by Application K Units (2025-2030)
  • Table 590. Italy Aesthetic Medicine Sales, by End Use K Units (2025-2030)
  • Table 591. Italy Aesthetic Medicine Sales, by Sales Channel K Units (2025-2030)
  • Table 592. Italy Aesthetic Medicine Sales, by Procedure K Units (2025-2030)
  • Table 593. United Kingdom Aesthetic Medicine Sales, by Type K Units (2025-2030)
  • Table 594. United Kingdom Aesthetic Medicine Sales, by Application K Units (2025-2030)
  • Table 595. United Kingdom Aesthetic Medicine Sales, by End Use K Units (2025-2030)
  • Table 596. United Kingdom Aesthetic Medicine Sales, by Sales Channel K Units (2025-2030)
  • Table 597. United Kingdom Aesthetic Medicine Sales, by Procedure K Units (2025-2030)
  • Table 598. Netherlands Aesthetic Medicine Sales, by Type K Units (2025-2030)
  • Table 599. Netherlands Aesthetic Medicine Sales, by Application K Units (2025-2030)
  • Table 600. Netherlands Aesthetic Medicine Sales, by End Use K Units (2025-2030)
  • Table 601. Netherlands Aesthetic Medicine Sales, by Sales Channel K Units (2025-2030)
  • Table 602. Netherlands Aesthetic Medicine Sales, by Procedure K Units (2025-2030)
  • Table 603. Rest of Europe Aesthetic Medicine Sales, by Type K Units (2025-2030)
  • Table 604. Rest of Europe Aesthetic Medicine Sales, by Application K Units (2025-2030)
  • Table 605. Rest of Europe Aesthetic Medicine Sales, by End Use K Units (2025-2030)
  • Table 606. Rest of Europe Aesthetic Medicine Sales, by Sales Channel K Units (2025-2030)
  • Table 607. Rest of Europe Aesthetic Medicine Sales, by Procedure K Units (2025-2030)
  • Table 608. MEA Aesthetic Medicine Sales, by Country K Units (2025-2030)
  • Table 609. MEA Aesthetic Medicine Sales, by Type K Units (2025-2030)
  • Table 610. MEA Aesthetic Medicine Sales, by Application K Units (2025-2030)
  • Table 611. MEA Aesthetic Medicine Sales, by End Use K Units (2025-2030)
  • Table 612. MEA Aesthetic Medicine Sales, by Sales Channel K Units (2025-2030)
  • Table 613. MEA Aesthetic Medicine Sales, by Procedure K Units (2025-2030)
  • Table 614. Middle East Aesthetic Medicine Sales, by Type K Units (2025-2030)
  • Table 615. Middle East Aesthetic Medicine Sales, by Application K Units (2025-2030)
  • Table 616. Middle East Aesthetic Medicine Sales, by End Use K Units (2025-2030)
  • Table 617. Middle East Aesthetic Medicine Sales, by Sales Channel K Units (2025-2030)
  • Table 618. Middle East Aesthetic Medicine Sales, by Procedure K Units (2025-2030)
  • Table 619. Africa Aesthetic Medicine Sales, by Type K Units (2025-2030)
  • Table 620. Africa Aesthetic Medicine Sales, by Application K Units (2025-2030)
  • Table 621. Africa Aesthetic Medicine Sales, by End Use K Units (2025-2030)
  • Table 622. Africa Aesthetic Medicine Sales, by Sales Channel K Units (2025-2030)
  • Table 623. Africa Aesthetic Medicine Sales, by Procedure K Units (2025-2030)
  • Table 624. North America Aesthetic Medicine Sales, by Country K Units (2025-2030)
  • Table 625. North America Aesthetic Medicine Sales, by Type K Units (2025-2030)
  • Table 626. North America Aesthetic Medicine Sales, by Application K Units (2025-2030)
  • Table 627. North America Aesthetic Medicine Sales, by End Use K Units (2025-2030)
  • Table 628. North America Aesthetic Medicine Sales, by Sales Channel K Units (2025-2030)
  • Table 629. North America Aesthetic Medicine Sales, by Procedure K Units (2025-2030)
  • Table 630. United States Aesthetic Medicine Sales, by Type K Units (2025-2030)
  • Table 631. United States Aesthetic Medicine Sales, by Application K Units (2025-2030)
  • Table 632. United States Aesthetic Medicine Sales, by End Use K Units (2025-2030)
  • Table 633. United States Aesthetic Medicine Sales, by Sales Channel K Units (2025-2030)
  • Table 634. United States Aesthetic Medicine Sales, by Procedure K Units (2025-2030)
  • Table 635. Canada Aesthetic Medicine Sales, by Type K Units (2025-2030)
  • Table 636. Canada Aesthetic Medicine Sales, by Application K Units (2025-2030)
  • Table 637. Canada Aesthetic Medicine Sales, by End Use K Units (2025-2030)
  • Table 638. Canada Aesthetic Medicine Sales, by Sales Channel K Units (2025-2030)
  • Table 639. Canada Aesthetic Medicine Sales, by Procedure K Units (2025-2030)
  • Table 640. Mexico Aesthetic Medicine Sales, by Type K Units (2025-2030)
  • Table 641. Mexico Aesthetic Medicine Sales, by Application K Units (2025-2030)
  • Table 642. Mexico Aesthetic Medicine Sales, by End Use K Units (2025-2030)
  • Table 643. Mexico Aesthetic Medicine Sales, by Sales Channel K Units (2025-2030)
  • Table 644. Mexico Aesthetic Medicine Sales, by Procedure K Units (2025-2030)
  • Table 645. Aesthetic Medicine: by Type(USD/Units)
  • Table 646. Research Programs/Design for This Report
  • Table 647. Key Data Information from Secondary Sources
  • Table 648. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Aesthetic Medicine: by Type USD Million (2018-2023)
  • Figure 5. Global Aesthetic Medicine: by Application USD Million (2018-2023)
  • Figure 6. Global Aesthetic Medicine: by End Use USD Million (2018-2023)
  • Figure 7. Global Aesthetic Medicine: by Sales Channel USD Million (2018-2023)
  • Figure 8. Global Aesthetic Medicine: by Procedure USD Million (2018-2023)
  • Figure 9. South America Aesthetic Medicine Share (%), by Country
  • Figure 10. Asia Pacific Aesthetic Medicine Share (%), by Country
  • Figure 11. Europe Aesthetic Medicine Share (%), by Country
  • Figure 12. MEA Aesthetic Medicine Share (%), by Country
  • Figure 13. North America Aesthetic Medicine Share (%), by Country
  • Figure 14. Global Aesthetic Medicine: by Type K Units (2018-2023)
  • Figure 15. Global Aesthetic Medicine: by Application K Units (2018-2023)
  • Figure 16. Global Aesthetic Medicine: by End Use K Units (2018-2023)
  • Figure 17. Global Aesthetic Medicine: by Sales Channel K Units (2018-2023)
  • Figure 18. Global Aesthetic Medicine: by Procedure K Units (2018-2023)
  • Figure 19. South America Aesthetic Medicine Share (%), by Country
  • Figure 20. Asia Pacific Aesthetic Medicine Share (%), by Country
  • Figure 21. Europe Aesthetic Medicine Share (%), by Country
  • Figure 22. MEA Aesthetic Medicine Share (%), by Country
  • Figure 23. North America Aesthetic Medicine Share (%), by Country
  • Figure 24. Global Aesthetic Medicine: by Type USD/Units (2018-2023)
  • Figure 25. Global Aesthetic Medicine share by Players 2023 (%)
  • Figure 26. Global Aesthetic Medicine share by Players (Top 3) 2023(%)
  • Figure 27. Global Aesthetic Medicine share by Players (Top 5) 2023(%)
  • Figure 28. BCG Matrix for key Companies
  • Figure 29. Allergan (Ireland) Revenue, Net Income and Gross profit
  • Figure 30. Allergan (Ireland) Revenue: by Geography 2023
  • Figure 31. Alma Laser (United States) Revenue, Net Income and Gross profit
  • Figure 32. Alma Laser (United States) Revenue: by Geography 2023
  • Figure 33. Cynosure (United States) Revenue, Net Income and Gross profit
  • Figure 34. Cynosure (United States) Revenue: by Geography 2023
  • Figure 35. Galderma (Switzerland) Revenue, Net Income and Gross profit
  • Figure 36. Galderma (Switzerland) Revenue: by Geography 2023
  • Figure 37. Johnson and Johnson (United States) Revenue, Net Income and Gross profit
  • Figure 38. Johnson and Johnson (United States) Revenue: by Geography 2023
  • Figure 39. Solta Medical International Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 40. Solta Medical International Inc. (United States) Revenue: by Geography 2023
  • Figure 41. Syneron Medical (United States) Revenue, Net Income and Gross profit
  • Figure 42. Syneron Medical (United States) Revenue: by Geography 2023
  • Figure 43. Skin Tech Pharma Group (Spain) Revenue, Net Income and Gross profit
  • Figure 44. Skin Tech Pharma Group (Spain) Revenue: by Geography 2023
  • Figure 45. Sinclair Pharm (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 46. Sinclair Pharm (United Kingdom) Revenue: by Geography 2023
  • Figure 47. Candela Medical (United States) Revenue, Net Income and Gross profit
  • Figure 48. Candela Medical (United States) Revenue: by Geography 2023
  • Figure 49. Lumenis (Israel) Revenue, Net Income and Gross profit
  • Figure 50. Lumenis (Israel) Revenue: by Geography 2023
  • Figure 51. Global Aesthetic Medicine: by Type USD Million (2025-2030)
  • Figure 52. Global Aesthetic Medicine: by Application USD Million (2025-2030)
  • Figure 53. Global Aesthetic Medicine: by End Use USD Million (2025-2030)
  • Figure 54. Global Aesthetic Medicine: by Sales Channel USD Million (2025-2030)
  • Figure 55. Global Aesthetic Medicine: by Procedure USD Million (2025-2030)
  • Figure 56. South America Aesthetic Medicine Share (%), by Country
  • Figure 57. Asia Pacific Aesthetic Medicine Share (%), by Country
  • Figure 58. Europe Aesthetic Medicine Share (%), by Country
  • Figure 59. MEA Aesthetic Medicine Share (%), by Country
  • Figure 60. North America Aesthetic Medicine Share (%), by Country
  • Figure 61. Global Aesthetic Medicine: by Type K Units (2025-2030)
  • Figure 62. Global Aesthetic Medicine: by Application K Units (2025-2030)
  • Figure 63. Global Aesthetic Medicine: by End Use K Units (2025-2030)
  • Figure 64. Global Aesthetic Medicine: by Sales Channel K Units (2025-2030)
  • Figure 65. Global Aesthetic Medicine: by Procedure K Units (2025-2030)
  • Figure 66. South America Aesthetic Medicine Share (%), by Country
  • Figure 67. Asia Pacific Aesthetic Medicine Share (%), by Country
  • Figure 68. Europe Aesthetic Medicine Share (%), by Country
  • Figure 69. MEA Aesthetic Medicine Share (%), by Country
  • Figure 70. North America Aesthetic Medicine Share (%), by Country
  • Figure 71. Global Aesthetic Medicine: by Type USD/Units (2025-2030)
List of companies from research coverage that are profiled in the study
  • Allergan (Ireland)
  • Alma Laser (United States)
  • Cynosure (United States)
  • Galderma (Switzerland)
  • Johnson and Johnson (United States)
  • Solta Medical International Inc. (United States)
  • Syneron Medical (United States)
  • Skin Tech Pharma Group (Spain)
  • Sinclair Pharm (United Kingdom)
  • Candela Medical (United States)
  • Lumenis (Israel)
Select User Access Type

Key Highlights of Report


Mar 2024 216 Pages 89 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Aesthetic Medicine Quantitative research analysis
Global Aesthetic Medicine Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Allergan (Ireland), Alma Laser (United States), Cynosure (United States), Galderma (Switzerland), Johnson and Johnson (United States), Solta Medical International Inc. (United States), Syneron Medical (United States), Skin Tech Pharma Group (Spain), Sinclair Pharm (United Kingdom), Candela Medical (United States) and Lumenis (Israel) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"The rising popularity of non-invasive aesthetic medicines" is seen as one of major influencing trends for Aesthetic Medicine Market during projected period 2023-2030.
The Aesthetic Medicine market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Aesthetic Medicine Report?

Have a Query? Click Here

Other Related Reports

Cold Remedies Comprehensive Study by Drug (Antihistamines, Expectorants, Bronchodilators, Decongestants, Antibiotics), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, Super...
$ 3650
Botanical and Plant-Derived Drugs Comprehensive Study by Type (Terpenes, Steroids, Glycosides, Phenols), Application (Oncology, Dermatology, CNS disorders, Hormone diseases) Players and Region - Glob...
$ 3500
Dry Eye Drugs Comprehensive Study by Type (Artificial Tears, Anti-inflammatory Drugs), Application (Hospital Pharmacies, Drug Stores, Online Pharmacies), Treatment (Topical Cyclosporine A Eye Drops, ...
$ 3750
Optic Neuropathy Drug Comprehensive Study by Type (BA-240, IWP-953, LM-22A4, Others), Application (Hospitals, Ophthalmic clinics, Ambulatory Surgical Centres), Distribution Channel (Prescription Drug...
$ 3350
Sexual Enhancement Supplements Comprehensive Study by Type (Male Sexual Enhancement Supplements, Female Sexual Enhancement Supplements), Application (Individual Use, Commercial Use), Distribution Cha...
$ 3750
Fetal Bovine Serum Comprehensive Study by Application (Drug Discovery, Cell Culture Media, Vitro Fertilization, Human and Animal Vaccine production, Diagnostics, Others), End-Users (Research and Acad...
$ 3450